Cellport Systems v. Peiker Acustic
Tyco Healthcare Grp. v. Mut. Pharm. Co

Amdocs Ltd. v. Openet Telecom, Inc.

Before the district court, Openet moved for summary judgment of noninfringement of the four patents. With regard to three of the patents, U.S. Patent Nos. 7,631,065 (the “’065 Patent”), 7,412,510 (the “’510 Patent”), and 6,947,984 (the “’984 Patent”), Openet argued that Amdocs was unable to point to actual infringing use and that the accused products did not practice all claim limitations. The district court granted Openet’s motion based on its finding that Amdocs did not raise a genuine question of material fact as to whether the accused devices practiced “completing” or “enhance[ing]” “in a distributed fashion,” a requirement which it construed to be common to all asserted claims. We agree with the court’s construction of enhancement and completion but we find that Amdocs’ documentary evidence describing the structure and operation of the accused product creates genuine factual issues regarding whether the product meets these constructions. Accordingly, for these three patents, we reverse the district court’s grant of summary judgment and remand.

Download Amdocs Ltd. v. Openet Telecom, Inc.

Registering your trademarks is one of the best long-term investments you can make in your business. Contact us today for more information.

Visit Gehrke & Associates, SC.


Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)